For example, the anti-tumor effects of SERPINE1 inhibitors have been explored in various cancers, and SERPINE1 inhibitors may constitute a viable therapeutic strategy for PFAS-induced HCC. This evidence concerns the gene PFAS and hepatocellular carcinoma.